US · Healthcare

X4 Pharmaceuticals Inc (XFOR)

Biotechnology

X4 Pharmaceuticals Inc (XFOR) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for XFOR

P/E ratio

25.00

X4 Pharmaceuticals Inc (XFOR) — FAQ

What is XFOR's P/E ratio?

The price-to-earnings (P/E) ratio for X4 Pharmaceuticals Inc (XFOR) is 25.00 (data as of 2026-05-23).

Does X4 Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for X4 Pharmaceuticals Inc (XFOR). Check the MyAverix Finance app for the latest dividend data.

What sector is X4 Pharmaceuticals Inc in?

X4 Pharmaceuticals Inc (XFOR) is classified in the Healthcare sector (Biotechnology industry).

What exchange is XFOR listed on?

XFOR is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)